Search results for "Thrombosis."

showing 10 items of 624 documents

Impaired Cerebrovascular Autoregulation in Large Vessel Occlusive Stroke after Successful Mechanical Thrombectomy: A Prospective Cohort Study

2020

Abstract Introduction: Successful thrombectomy improves morbidity and mortality after stroke. The present prospective, observational cohort study investigated a potential correlation between the successful restoration of tissue perfusion by mechanical thrombectomy and intact cerebrovascular autoregulation (CA). Objective: Status of CA in patients with large vessel occlusive stroke after thrombectomy. Methods: After thrombectomy CA was measured using transcranial Doppler ultrasound. For this purpose a moving correlation index (Mxa) based on spontaneous arterial blood pressure fluctuations and corresponding cerebral blood flow velocity changes was calculated. CA impairment was defined by Mxa …

Malemedicine.medical_specialtyTime FactorsUltrasonography Doppler TranscranialPerfusion scanningBrain Ischemia03 medical and health sciences0302 clinical medicinemedicine.arteryInternal medicinemedicineHomeostasisHumansArterial PressureProspective StudiesProspective cohort studyStrokeAgedThrombectomyAged 80 and overbusiness.industryRehabilitationRecovery of Functionmedicine.diseaseTranscranial DopplerStrokeTreatment OutcomeBlood pressureCerebral blood flowCerebrovascular CirculationMiddle cerebral arteryCardiologyFemaleSurgeryNeurology (clinical)Intracranial ThrombosisInternal carotid arteryCardiology and Cardiovascular MedicinebusinessBlood Flow Velocity030217 neurology & neurosurgeryJournal of Stroke and Cerebrovascular Diseases
researchProduct

Comparison between local and regional anesthesia in arteriovenous fistula creation.

2011

Purpose Assessment of the effectiveness of Brachial Plexus Block (BPB) via axillary approach compared to regional anesthesia for arteriovenous fistula surgery in patients affected by end-stage renal disease. Methods We compared forty patients randomly divided into two groups. Group A underwent BPB procedure with 15 mL ropivacaine 1% and 10 mL of saline (0.9% NaCl) via axillary approach. Group B received local anesthesia with lidocaine 2%. The forearm blood vessels were assessed by Doppler ultrasonography before and after the intervention. Results BPB performed on Group A was associated with a considerable venous dilation and a significant decrease (48.7%, P<.05) in pulsatility index (PI)…

Malemedicine.medical_specialtyTime Factorslocal and regional anesthesiaFistulaArteriovenous fistulaSettore MED/41 - AnestesiologiaVeinsArteriovenous Shunt SurgicalForearmRenal DialysisOcclusionmedicineHumansLocal anesthesiaBrachial PlexusRopivacaineAnesthetics Localarteriovenous fistulaBrachial plexus blockarteriovenous fistula; local and regional anesthesiaAgedRopivacainebusiness.industryLidocaineNerve BlockUltrasonography DopplerMiddle Agedmedicine.diseaseThrombosisAmidesSurgeryVasodilationSettore MED/18 - Chirurgia GeneraleForearmmedicine.anatomical_structureTreatment OutcomeItalyNephrologyAnesthesiaRadial ArteryKidney Failure ChronicSurgeryFemalebusinessmedicine.drugAnesthesia LocalThe journal of vascular access
researchProduct

Initial Clinical Experience Using the Low-Profile Altura Endograft System With Double D-Shaped Proximal Stents for Endovascular Aneurysm Repair.

2018

Purpose: To report the initial clinical results of endovascular aneurysm repair (EVAR) using the low-profile (14-F) Altura Endograft System, which features a double “D-shaped” stent design with suprarenal fixation and modular iliac components that are deployed from distal to proximal. Methods: From 2011 to 2015, 90 patients (mean age 72.8±8.3 years; 79 men) with abdominal aortic aneurysm (AAA; mean diameter 53.8±5.7 mm) were treated at 10 clinical sites in 2 prospective, controlled clinical studies using the Altura endograft. Outcomes evaluated included mortality, major adverse events (MAEs: all-cause death, stroke, paraplegia, myocardial infarction, respiratory failure, bowel ischemia, an…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatment030204 cardiovascular system & hematologyProsthesis DesignEndovascular aneurysm repairRisk Assessment03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicinePostoperative ComplicationsRisk FactorsmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineMyocardial infarctionAdverse effectStrokeAgedAged 80 and overbusiness.industryPatient SelectionEndovascular ProceduresMiddle Agedmedicine.diseaseThrombosisAbdominal aortic aneurysmSurgeryBlood Vessel ProsthesisProsthesis FailureTreatment OutcomeRespiratory failureSurgeryFemaleStentsCardiology and Cardiovascular MedicineParaplegiabusinessAortic Aneurysm AbdominalJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
researchProduct

Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).

2007

Objective Femoropopliteal bypass still is the standard surgical therapy for disabling claudication and critical ischemia. When autologous vein is not suitable synthetic or biological prostheses may be considered. Second generation glutaraldehyde tanned human umbilical vein (HUV) graft was chosen for above and below knee femoropopliteal bypass when autologous vein was not available. A single center experience regarding long-term graft function, secondary reinterventions, and potential biodegeneration of the HUV is presented. Methods Between January 1994 and January 2005, 211 consecutive femoropopliteal bypass operations with HUV (65 above knee and 146 below knee) were performed in 197 patien…

Malemedicine.medical_specialtyUmbilical VeinsTime FactorsTissue FixationAnastomosisProsthesis DesignSeverity of Illness IndexBlood Vessel Prosthesis ImplantationFixativesAneurysmIschemiamedicineHumansPopliteal ArteryDerivationVeinVascular PatencyAgedRetrospective StudiesUltrasonographyAged 80 and overBioprosthesismedicine.diagnostic_testbusiness.industryGreat saphenous veinGraft Occlusion VascularThrombosisIntermittent ClaudicationMiddle Agedmedicine.diseaseLimb SalvageThrombosisSurgeryBlood Vessel ProsthesisFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremityGlutaralAngiographySurgeryFemaleRadiologymedicine.symptombusinessClaudicationCardiology and Cardiovascular MedicineFollow-Up StudiesJournal of vascular surgery
researchProduct

D-Dimer and thrombus burden in acute pulmonary embolism.

2018

Abstract Background Thrombus burden in pulmonary embolism (PE) is associated with higher D-Dimer-levels and poorer prognosis. We aimed to investigate i) the influence of right ventricular dysfunction (RVD), deep venous thrombosis (DVT), and high-risk PE-status on D-Dimer-levels and ii) effectiveness of D-Dimer to predict RVD in normotensive PE patients. Methods Overall, 161 PE patients were analyzed retrospectively, classified in 5 subgroups of thrombus burden according to clinical indications and compared regarding D-Dimer-levels. Linear regression models were computed to investigate the association between D-Dimer and the groups. In hemodynamically stable PE patients, a ROC curve was calc…

Malemedicine.medical_specialtyVentricular Dysfunction Right030204 cardiovascular system & hematologyLogistic regressionFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineInternal medicineD-dimerLinear regressionmedicineHumans030212 general & internal medicineAgedRetrospective StudiesVenous Thrombosisbusiness.industryCancerGeneral Medicinemedicine.diseasePrognosisPulmonary embolismVenous thrombosisPneumoniaROC CurveThrombus burdenAcute DiseaseEmergency MedicineCardiologyFemalebusinessPulmonary EmbolismBiomarkersThe American journal of emergency medicine
researchProduct

Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10

2009

SummaryUnanticipated elevation of the INR is common in patients receiving warfarin. We performed a prospective cohort study of 107 warfarintreated patients with INR values of more than 10 who received a single 2.5 mg dose of oral vitamin K. During the first week, one patient experienced major bleeding, and one died. In the first 90 days after enrolment four patients had major bleeding (3.7%, 1.0% to 9.3%), eight patients (7.5%, 3.3% to 14.2%) died and two had objectively confirmed thromboembolism. Based on our low rate of observed major bleeding we conclude that 2.5 mg of oral vitamin K is a reasonable treatment for patients with INR values of more than 10 who are not actively bleeding.

Malemedicine.medical_specialtyVitamin Kmedicine.drug_classAdministration OralHemorrhagePharmacotherapyInternal medicinemedicineCoagulopathyHumansInternational Normalized RatioProspective StudiesProspective cohort studyAgedAged 80 and overVenous ThrombosisVascular diseasebusiness.industryAnticoagulantWarfarinAnticoagulantsHematologyMiddle Agedmedicine.diseaseThrombosisSurgeryFemaleINR oral anticoagulantsWarfarinbusinessFollow-Up Studiesmedicine.drugCohort studyThrombosis and Haemostasis
researchProduct

Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism

2021

Abstract Background Venous thromboembolism (VTE) is common and associated with high morbidity and mortality. Although chronic inflammation was not categorized as a traditional risk factor for VTE, chronic inflammation might increase the risk to develop VTE events. While studies confirmed an increased cardiovascular morbidity and mortality in psoriatic patients, data regarding the influence of psoriasis on patients' cardiovascular profile and on prognosis of patients with pulmonary embolism (PE) are sparse. Purpose We aimed to investigate the impact of psoriasis on prognosis of PE patients. Methods Hospitalized PE patients were stratified for psoriasis and the impact of psoriasis on outcome …

Malemedicine.medical_specialtyYounger agebusiness.industryVenous Thromboembolismmedicine.diseasePulmonary embolismVenous thrombosisIncreased riskRisk FactorsInternal medicinePsoriasismedicineHumansPsoriasisFemaleHospital MortalityPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessVenous thromboembolismAgedEuropean Heart Journal
researchProduct

Acute inferior myocardial infarction due to a large thrombus in the Left coronary sinus of valsalva.

2021

Background Masses in the ascending aorta are an uncommon source of coronary embolism: thrombi located on atherosclerotic aortic plaques are the most frequent cause. A floating thrombus, without evidence of ascending aortic pathology has rarely been reported Method We report a case of an unusual aortic route thromboembolism leading ST segment elevation Myocardial Infarction (STEMI). The patient was referred to the Hub Hospital to undergo urgent coronarography. The examination excluded atherosclerotic coronary arteries disease but an unusual persistence of contrast dye was found at the level of non-coronary sinus. The trans-esophageal echocardiography showed a mobile pedunculated echogenic ma…

Malemedicine.medical_specialtybusiness.industryAcute Inferior Myocardial InfarctionThrombosisGeneral MedicineInferior Wall Myocardial InfarctionSinus of ValsalvaCoronary embolismmedicine.diseaseInternal medicinemedicineCardiologyHumansThrombusMyocardial Infarction with Non Obstructive Coronary Artery (MINOCA) Aortic routeThrombectomy Coronary EmbolismCardiology and Cardiovascular MedicinebusinessCoronary sinusAgedCoronary artery disease
researchProduct

Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study

2017

Essentials Isolated distal deep vein thrombosis (IDDVT) is frequently associated with cancer. No study has specifically evaluated the long-term clinical course of cancer-associated IDDVT. Patients with cancer-associated IDDVT are at very high risk of symptomatic recurrence and death. We observed low rates of major bleeding during anticoagulation. SummaryBackground Although isolated distal deep vein thrombosis (IDDVT) is frequently associated with cancer, no study has specifically evaluated the long-term clinical course of IDDVT in this setting. Aim To provide data on the rate of recurrent venous thromboembolism (VTE), major bleeding events and death in IDDVT patients with active cancer. Pat…

Malemedicine.medical_specialtydistal deep vein thrombosis; mortality; neoplasm; observational study; venous thromboembolism; HematologyTime FactorsDeep veinHemorrhage030204 cardiovascular system & hematologyDisease-Free Survival03 medical and health sciences0302 clinical medicineRecurrenceRisk FactorsNeoplasmsInternal medicinemedicineHumans030212 general & internal medicineAgedProportional Hazards ModelsRetrospective StudiesVenous ThrombosisHematologybusiness.industryIncidenceClinical courseAnticoagulantsCancerdistal deep vein thrombosiVenous ThromboembolismHematologyHeparinMiddle Agedmedicine.diseasemortalityThrombosisSurgeryTreatment Outcomemedicine.anatomical_structureItalyobservational studyFemaledistal deep vein thrombosisPulmonary EmbolismbusinessVenous thromboembolismneoplasmDistal deep vein thrombosis; Mortality; Neoplasm; Observational study; Venous thromboembolism; Hematologymedicine.drugCohort studyJournal of Thrombosis and Haemostasis
researchProduct

Acute dialysis: PMN-elastase as a new parameter for controlling individual anticoagulation with low molecular weight heparin (Fragmin).

1991

Despite the improvements in the development of dialyzer membranes with greater hemocompatibility, an activation of the coagulation system occurs when blood comes into contact with exogenous surfaces. The large number of heparin dosage regimens demonstrate the difficulty to adapt general therapeutic guidelines. Low molecular weight heparin (Fragmin®) was administered as a single bolus dose for anticoagulation during 58 acute dialyses. Anti-Xa-activity, the plasma levels of the lysosomal elastase of the polymorphnuclear granulocytes (“PMN-elastase”) and of the thrombin-antithrombin III-complex (TAT) were measured at hourly intervals. Therapeutic anti-Xa-levels did not show evidence of suffici…

Malemedicine.medical_specialtymedicine.drug_classAntithrombin IIILow molecular weight heparinPharmacologyCritical Care and Intensive Care MedicineRenal DialysismedicineHumansPancreatic elastaseAgedbiologyPancreatic Elastasebusiness.industryElastaseAnticoagulantThrombosisHeparinAcute Kidney InjuryHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisSurgeryCoagulationNeutrophil elastasebiology.proteinFemalebusinessLeukocyte Elastasemedicine.drugPeptide HydrolasesIntensive care medicine
researchProduct